A Multicenter, Randomized, Double Blind, Double Dummy, Parallel-Group Efficacy Study Comparing 8 Weeks of Treatment With Esomeprazole Magnesium (40mg qd) to Lansoprazole (30mg qd) for the Healing of Erosive Esophagitis in Patients With Moderate or Severe Erosive Esophagitis

PHASE4CompletedINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

December 31, 2002

Primary Completion Date

August 31, 2003

Study Completion Date

August 31, 2003

Conditions
Erosive Esophagitis
Interventions
DRUG

Esomeprazole

40mg once daily

DRUG

Lansoprazole

30mg once daily

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY